Becky Chen 1 and Richard A. Schreiber 2; 3 and Derek G. Human 3; 4 and James E. Potts 3; 4 and Orlee R. Guttman 2; 3
Academic Editor:Eric M. Yoshida
1, Department of Pediatrics, Children's Hospital of Western Ontario, London, ON, Canada
2, Division of Gastroenterology, Hepatology and Nutrition, British Columbia Children's Hospital, Vancouver, BC, Canada
3, University of British Columbia, Vancouver, BC, Canada
4, Children's Heart Centre, British Columbia Children's Hospital, Vancouver, BC, Canada
Received 11 October 2016; Accepted 15 October 2016; 8 February 2017
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We thank Drs. Xue and Cai for their interest in our study and we appreciate their comments regarding its design [1, 2]. They identify an important factor in the interpretation of transient elastography (TE) results, namely, the potential for falsely elevated values in the context of raised alanine aminotransferase (ALT).
As referenced in our paper, recent data suggest that TE values may be 1.3-3 times higher in the setting of acute liver inflammation and moderately elevated ALT [3]. In the 2012 study by Tapper et al., increased levels of ALT correlated with liver stiffness among hepatitis C patients with METAVIR scores 0-2. A recent study of pediatric patients with a variety of liver diseases similarly found that the correlation between ALT and TE result was stronger among those with inflammatory diagnoses and F0/F1 fibrosis [4].
The patients included in the studies referenced by Drs. Xue and Cai all had acute or chronic hepatitis from inflammatory conditions, namely, infectious (HAV, HBV, and HCV), toxic, or autoimmune diagnoses. This is in important contrast to our cohort of Fontan patients. Histologic studies of liver biopsies after Fontan demonstrate varying degrees of portal and sinusoidal fibrosis, but inflammatory changes are quite rare [5, 6].
In our study, although the ALT levels among Fontan patients were significantly higher than those in the healthy controls, the absolute levels of ALT were within the normal reference ranges provided by the respective laboratories (12.0-54.0 U/L). This is also in contrast to the above-mentioned studies, where a majority of patients had ALT values that were elevated, in some cases considerably so.
In summary, while it is important to interpret TE results thoughtfully in the context of hepatic inflammation and ALT elevation, we feel that this factor likely does not significantly contribute to the elevated TE values among our Fontan patients. TE values in our Fontan cohort likely represent the contributions of hepatic congestion and possible fibrosis. We agree, however, that further prospective studies involving TE are necessary to determine its optimal utility in this patient population.
[1] X. Xue, S. Cai, "Comment on 'Assessment of liver stiffness in pediatric Fontan patients using transient elastography',", Canadian Journal of Gastroenterology and Hepatology , vol. 2016, 2016.
[2] B. Chen, R. A. Schreiber, D. G. Human, "Assessment of liver stiffness in pediatric Fontan patients using transient elastography,", Canadian Journal of Gastroenterology and Hepatology , vol. 2016, 2016.
[3] E. B. Tapper, E. B. Cohen, K. Patel, B. Bacon, S. Gordon, E. Lawitz, D. Nelson, I. A. Nasser, T. Challies, N. Afdhal, "Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection,", Clinical Gastroenterology and Hepatology , vol. 10, no. 8, pp. 932-937, 2012.
[4] A. Raizner, N. Shillingford, P. D. Mitchell, S. Harney, R. Raza, J. Serino, M. M. Jonas, C. K. Lee, "Hepatic inflammation may influence liver stiffness measurements by transient elastography in children and young adults,", Journal of Pediatric Gastroenterology and Nutrition , 2016.
[5] C. H. Kiesewetter, N. Sheron, J. J. Vettukattill, N. Hacking, B. Stedman, H. Millward-Sadler, M. Haw, R. Cope, A. P. Salmon, M. C. Sivaprakasam, T. Kendall, B. R. Keeton, J. P. Iredale, G. R. Veldtman, "Hepatic changes in the failing Fontan circulation,", Heart , vol. 93, no. 5, pp. 579-584, 2007.
[6] T. J. Kendall, B. Stedman, N. Hacking, "Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study,", Journal of Clinical Pathology , vol. 61, pp. 504-508, 2008.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright © 2017 Becky Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Becky Chen 1 and Richard A. Schreiber 2; 3 and Derek G. Human 3; 4 and James E. Potts 3; 4 and Orlee R. Guttman 2; 3 Academic Editor:Eric M. Yoshida 1, Department of Pediatrics, Children's Hospital of Western Ontario, London, ON, Canada 2, Division of Gastroenterology, Hepatology and Nutrition, British Columbia Children's Hospital, Vancouver, BC, Canada 3, University of British Columbia, Vancouver, BC, Canada 4, Children's Heart Centre, British Columbia Children's Hospital, Vancouver, BC, Canada Received 11 October 2016; Accepted 15 October 2016; 8 February 2017 This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer